Contraception for adolescents with chronic rheumatic diseases.

about

Contraception for adolescents with chronic rheumatic diseases.

Item

http://www.wikidata.org/entity/Q38922218

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Contraception for adolescents with chronic rheumatic diseases.

@en

type

Item

label

Contraception for adolescents with chronic rheumatic diseases.

@en

prefLabel

Contraception for adolescents with chronic rheumatic diseases.

@en

P1476

Contraception for adolescents with chronic rheumatic diseases.

@en

P2093

Benito Lourenço

http://www.w3.org/2001/XMLSchema#string

Camila M P França

http://www.w3.org/2001/XMLSchema#string

Clovis A Silva

http://www.w3.org/2001/XMLSchema#string

Elisabeth G C Fernandes

http://www.w3.org/2001/XMLSchema#string

Fernando H C Souza

http://www.w3.org/2001/XMLSchema#string

Gabriela N Leal

http://www.w3.org/2001/XMLSchema#string

Katia T Kozu

http://www.w3.org/2001/XMLSchema#string

Marco F Silva

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis

Estimates of contraceptive failure from the 2002 National Survey of Family Growth

Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies.

Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

Contraception for adolescents with lupus.

Long-acting reversible contraception for adolescents

Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.

The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.

Changes in use of long-acting contraceptive methods in the United States, 2007-2009.

P2888

j.rbr.2016.06.005

P31

scholarly article

P356

10.1016/J.RBR.2016.06.005

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037307694

http://www.w3.org/2001/XMLSchema#string

P698

27502765

http://www.w3.org/2001/XMLSchema#string

P921

contraception

teenager